 |
 |

Brain Monoamine Oxidase Activity in Schizophrenics and Controls
Michael A. Reveley, MD, MRCPsych;
Vivette Glover, MA, PhD;
Merton Sandler, MD, FRCP, FRCPath;
Ernest G. Spokes, MD, MRCP
Arch Gen Psychiatry. 1981;38(6):663-665.
Abstract
Postmortem samples of caudate nucleus and frontal cortex from schizophrenic, schizophrenic-like, and control subjects were examined for monoamine oxidase activity using dopamine, phenylethylamine, and 5-hydroxytryptamine as substrates. There were no significant differences between the diagnostic groups with any of the three substrates. Neither was there a difference between the sexes, nor a consistent relationship of enzyme activity to age.
Author Affiliations
From Bernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte's Maternity Hospital, London (Drs Reveley, Glover, and Sandler); and the Medical Research Council Neurochemical Pharmacology Unit, University of Cambridge, England (Dr Spokes). Dr Reveley is now with the Institute of Psychiatry, London.
Footnotes
Accepted for publication Oct 14, 1980.
Reprint requests to Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, England (Dr Reveley).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|